MedTrace Logo

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

NCT00075699 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 840

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Active symptom control may decrease chest pain, breathlessness, sweating, and general discomfort in patients with malignant pleural mesothelioma. It is not yet known if active symptom control is more effective with or without chemotherapy.

PURPOSE: This randomized phase III trial is studying active symptom control and chemotherapy to see how well they work compared to active symptom control alone in treating patients with malignant pleural mesothelioma.

Conditions

  • Malignant Mesothelioma

Interventions

DRUG

cisplatin

DRUG

mitomycin C

DRUG

vincristine sulfate

DRUG

vinorelbine tartrate

PROCEDURE

pain therapy

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

Principal Investigators

  • Martin F. Muers, MD · Leeds General Infirmary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00075699 on ClinicalTrials.gov